Similarly, Chang et al (33) reported that gefitinib induced apoptosis via a p53-dependent pathway in a lung cancer cell model, which was accompanied by the upregulation of pro-apoptotic molecules (such as Fas and PUMA) and the downregulation of anti-apoptotic molecules (such as XIAP and survivin). The gene discussed is BIRC5; the disease is lung carcinoma.